Dezeen Debate features "successor to the annoying AI hype"
The latest edition of our Dezeen Debate newsletter features news that Apple is developing products that can be controlled using brain implants. Subscribe to Dezeen Debate now. Designed to allow users with physical disabilities to operate their devices just by thinking, the software would allow Apple devices to be controlled by Synchron's stent-like implant placed The post Dezeen Debate features "successor to the annoying AI hype" appeared first on Dezeen.


The latest edition of our Dezeen Debate newsletter features news that Apple is developing products that can be controlled using brain implants. Subscribe to Dezeen Debate now.
Designed to allow users with physical disabilities to operate their devices just by thinking, the software would allow Apple devices to be controlled by Synchron's stent-like implant placed on top of the brain's motor cortex.
Readers were amused, with one remarking, "so, there's finally a successor to the annoying AI hype?" and another calling it "a radical turn".
Other stories in this week's newsletter that fired up the comments section included Purcell's renovation of the Elizabeth Tower winning a RIBA London Award, Landini Associates' colourful revamp of the Admiralty McDonald's in Hong Kong and a coastal villa in Andalusia with zigzagging stone volumes.
Dezeen Debate
Dezeen Debate is sent every Tuesday and features a selection of the best reader comments and most talked-about stories. Read the latest edition of Dezeen Debate or subscribe here.
You can also subscribe to our other newsletters; Dezeen Agenda is sent every Tuesday containing a selection of the most important news highlights from the week, Dezeen Daily is our daily bulletin that contains every story published in the preceding 24 hours and Dezeen In Depth is sent on the last Friday of every month and delves deeper into the major stories shaping architecture and design.
The post Dezeen Debate features "successor to the annoying AI hype" appeared first on Dezeen.
What's Your Reaction?






